Protagenic Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:MBP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
12 Oct 23	Buy€6,142	Alexander Arrow	Individual		8,000	€0.77

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 15 shareholders own 59.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
32.1%	Robert Stein	1,390,784	€2.5m	0%	no data
17.1%	Garo Armen	738,489	€1.3m	0%	no data
5.54%	Armistice Capital, LLC	240,000	€424.4k	0%	0.01%
2.37%	Khalil Barrage	102,500	€181.2k	0%	no data
0.76%	The Vanguard Group, Inc.	32,951	€58.3k	-44.2%	no data
0.59%	Geode Capital Management, LLC	25,399	€44.9k	-1.93%	no data
0.43%	FNY Investment Advisers, LLC	18,750	€33.2k	0%	0.05%
0.32%	State Street Global Advisors, Inc.	13,812	€24.4k	0.01%	no data
0.064%	FSC Securities Corporation, Asset Management Arm	2,764	€4.9k	0.04%	no data
0.033%	Tower Research Capital LLC	1,438	€2.5k	-7.29%	no data
0.007%	UBS Asset Management AG	305	€539.1	-92.9%	no data
0.00053%	Wells Fargo & Company, Private Banking and Investment Banking Arm	23	€40.6	4.55%	no data
0.00002%	Morgan Stanley, Investment Banking and Brokerage Investments	1	€1.5	0%	no data
0.00002%	Bank of America Corporation, Asset Management Arm	1	€1.5	0%	no data
0.00002%	Jennifer Buell	1	€1.5	0%	no data